A study on salivary samples and nasopharyngeal samples in diagnosis of COVID-19 Disease Patients
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/05/025243
- Lead Sponsor
- Medanta Institute of Education and Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Adults above the age of 18 years, who give consent to collect saliva samples independently according to the CDC guidelines
The IPD/OPD adults who are confirmed positive and negative for COVID-19 infection, by rRT-PCR of NP swabs done at NABL accredited laboratory.
Exclusion Criteria
Patients who are on drugs affecting saliva production like anticholinergics.
Patients who have xerostomia or any active oral disease or injury.
Patients who are mechanically ventilated or critically ill.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the sensitivity and specificity of paired salivary samples and nasopharyngeal samples in diagnosis of COVID-19 infectionTimepoint: Day 0,7 and 14
- Secondary Outcome Measures
Name Time Method To compare result of both testsTimepoint: Day 0, 7 and 14